Target intelligence / Profile preview

Cellular plasma membrane (PM) (PM)

Target
PM
Molecular classification
Cellular structure, Lipid bilayer
01

Overview

The cellular plasma membrane is a semi-permeable lipid bilayer that defines the boundary of the cell, separating the intracellular environment from the extracellular space [1]. It is composed of phospholipids, cholesterol, and embedded proteins that facilitate essential processes such as signal transduction, nutrient transport, and ion homeostasis [1]. While not a single molecular target, the plasma membrane serves as a critical site for pharmacological intervention, particularly for antimicrobial agents that disrupt membrane integrity or form lethal pores [2]. In diseases like cancer, the composition and fluidity of the plasma membrane are often altered, affecting receptor signaling and drug uptake [3]. Drugs targeting the membrane, such as polymyxins or polyene antifungals, often rely on differences in lipid composition between host and pathogen cells to achieve selectivity [4]. However, because the membrane is a complex cellular structure rather than a discrete protein, drugs acting on it often face challenges regarding systemic toxicity and therapeutic index [2].

Other names
Cell membraneCytoplasmic membranePlasmalemmaLipid bilayer
02

Mechanism of action

Drugs targeting the cellular plasma membrane typically act through direct physical disruption of the lipid bilayer, the formation of transmembrane pores that lead to ion leakage and cell death, or the sequestration of specific membrane lipids such as ergosterol in fungi [2, 4].

03

Biological functions

Selective permeabilitySignal transductionCell-cell communicationIon homeostasisStructural support
04

Disease associations

InfectionCancerNeurodegenerative disease
05

Safety considerations

Lack of cell-type specificityHemolysisNephrotoxicitySystemic toxicity due to host membrane damage
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

Membrane lipid compositionMembrane fluidity index

Beyond the preview

Go deeper on Cellular plasma membrane (PM) (PM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular plasma membrane (PM) (PM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call